Clinical Trial Record

Return to Clinical Trials

Quality of Life After Radiofrequency Ablation of Pancreatic Cancer


2013-02


2014-01


2015-12


1

Study Overview

Quality of Life After Radiofrequency Ablation of Pancreatic Cancer

A prospective clinical study evaluating quality of life (QoL) in pancreatic cancer patients treated with intraoperative radiofrequency ablation (RFA).

N/A

  • Pancreatic Cancer
  • PROCEDURE: Radiofrequency ablation
  • NT 14579-3

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2015-12-18  

N/A  

2015-12-24  

2015-12-18  

N/A  

2015-12-28  

2015-12-22  

N/A  

2015-12  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Treatment


Allocation:
Na


Interventional Model:
Single Group


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: RFA group

Twenty-fourth consecutive patients with histologically proved pancreatic cancer [stage IIb (n=4), III (n=15), IV (n=5) ]underwent intraoperative RFA of primary tumor.

PROCEDURE: Radiofrequency ablation

  • After laparotomy, intraoperative IOUS quided RFA of primary tumor was performed.
Primary Outcome MeasuresMeasure DescriptionTime Frame
Quality of life after RFA of pancreatic cancerQuality of life will be evaluated using EORTC C 30 and pan 26 questionaire preoperatively and three months after RFA3 years
Secondary Outcome MeasuresMeasure DescriptionTime Frame
3- months perioperative morbidity and mortalityThree months morbidity and mortality will be evaluated using Dindo-Clavien classification3 years

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • histologically proved locally advanced or metastatic pancreatic cancer. Patients with histologically proved resectable pancreatic cancer with low Karnofsky index.

  • informed consent
    Exclusion Criteria:

  • cystic tumor

  • age under 18

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: Jan Hlavsa, MD, PhD, Department of surgery Masaryk University Hospital Brno

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available